Archives for March 2020

Canada SynBio 2020 Postponed

Given the global situation around COVID-19 and actions being taken by the Canadian, Quebec and Ontario governments, the Canada SynBio Organizing Committee had to make the difficult decision to postpone the upcoming Canada SynBio 2020 conference, originally scheduled for June 3 in Montreal. We are currently working to find a new date and will share the details as soon as they are confirmed.

As Canada SynBio 2020 was part of a larger “SynBio Week” series of events, please see below for their status:

  • June 1-2: The Global BioFoundries Alliance (GBA) has cancelled their AGM.
  • June 4: SynBio 5.0 has been cancelled.

We appreciate your understanding and sincerely apologize for any inconvenience this may have caused. During these difficult times, the health and wellbeing of the attendees, speakers, staff and general public remains our top priority.

You can follow us on Twitter for updates and check out www.candesyne.ca for upcoming news on our exciting engineering biology initiative.

Ontario Genomics: COVID-19 Update

Given the global response to the COVID-19 health emergency and specific actions being taken by the Canadian, Ontario and Toronto governments, Ontario Genomics is taking the following proactive measures to reduce the potential spread of the virus, prioritizing the health and safety of our staff and the broader community:

  • All Ontario Genomics staff are working from home until April 3*
  • All in-person workshops and meetings currently scheduled are moving online or have been postponed until further notice. If you have a meeting or event scheduled, we will coordinate with you to develop an alternative arrangement.
  • We are no longer taking face-to-face meetings at our office and will instead be setting up virtual meetings and teleconference calls, where appropriate.
  • All business travel has been suspended.
  • The Canada SynBio 2020 Organizing Committee has postponed the Canada SynBio 2020 conference originally planned for June 3, 2020, in Montreal. We are currently working to find a new date and will communicate the details with you as soon as we have this confirmed.

*All dates subject to change.

As the World Health Organization has declared COVID-19 a pandemic, and the Government of Ontario has declared a provincial emergency, we are closely monitoring the situation and adjusting our business operations based on the recommendations of Public Health Officials.

For further information on COVID-19, please refer to the following reliable sources:

If you have any questions, please don’t hesitate to contact us.

Genome Canada: Major investment in genomics research will improve the health and wellbeing of Canadians

Nearly $15 million in federal funding to support genomics research in health, agriculture and environment

March 2, 2020 – Montreal, Quebec – Canada is a world leader in genomics research, producing dramatic breakthroughs in science, and transforming our understanding of the world around us. The results of this research are being used to tackle important challenges and develop innovative solutions, not just in human health, but across diverse sectors of the economy.

Today, on behalf of Minister Navdeep Bains, William Amos, Parliamentary Secretary to Minister of Innovation, Science and Industry (Science), announced $14.7 million to support 11 genomics research projects awarded through Genome Canada. In addition, provincial governments, businesses and research partners are investing $29.7 million for a total of $44.4 million in support of these projects in the areas of health, agriculture and the environment.

This investment will support researchers at McGill University including Dr. Lucy Gilbert, who is working on DOvEEgene a new genomics tool for early detection of ovarian and endometrial cancers. Dr. Gilbert has partnered with Dr. Guy Rouleau and his team at the McGill University Health Centre (MUHC) on a genomic uterine pap test to screen for these cancers while they are at the early stages and still curable. This could save thousands of women’s lives and reduce healthcare costs by up to $250 million from the more than $1 billion that is currently spent each year on treatment for the 10,000 Canadian women who are diagnosed with these cancers.

Genomics research collaborations have real, positive impacts on the health and well-being of Canadians.

These networks of partnerships between the research sector and post-secondary institutions support the responsible uptake of new technology, and targeted investments in initiatives with economic and many other benefits to Canada.